Medicaid; authorizing flexible payment structures for prenatal, delivery, and postpartum care; effective date.
HB 3904 requires Oklahoma Medicaid to reimburse specific maternal health services for pregnant and postpartum women. It changes payment rules to separately cover prenatal, delivery, and postpartum care (instead of bundled payments), implements immediate presumptive eligibility for prenatal care, and adds reimbursement for depression screening, self-measured blood pressure monitoring, remote ultrasounds, and doula/community health worker services. The bill directs the Oklahoma Health Care Authority to adopt implementing rules and seek federal approvals, effective November 1, 2026. It directly affects Medicaid-covered pregnant and postpartum individuals in Oklahoma by expanding access to targeted health services.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2026
Committee Review
Apr 2026
House Passage
Mar 2026
Senate Passage
Governor
Introduced Feb 2, 2026
Last action Apr 16, 2026
Maddy AI version diff · 6 comparisons
What changed between versions
Floor (House)
→
Floor (Senate)
·
3 edits
MINOR
The bill was amended to transition from a House committee substitute to a Senate floor version, incorporating specific changes to the bill's title and effective date. The most significant substantive change is the shift in the effective date from an unspecified time to November 1, 2026, ensuring the new Medicaid payment rules take effect at the start of the next fiscal year. Additionally, the list of covered prenatal, delivery, and postpartum services was expanded to explicitly include continuous glucose monitors for gestational diabetes.
Scope change
The bill's scope regarding covered services was broadened by adding specific items like continuous glucose monitors to the list of reimbursable services.
TIMELINE
The effective date was changed to November 1, 2026, clarifying when the new payment rules will begin.
DEFINITION
The definition of covered services was updated to explicitly include continuous glucose monitors for gestational diabetes.
TECHNICAL
The document header was updated to reflect the Senate floor version, and the committee report section was altered to match Senate procedures.
Floor votes · House Mar 25, 2026
How they voted
83–12
Passed · 5 other
Total votes 100
Mar 25, 2026
D
Democratic18
100% Yea
R
Republican82
79% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
19
Key actions
5
Committee
6
Apr 8, 2026
Committee
Referred to Appropriations
upper
Apr 8, 2026
Upper · Passed
Reported Do Pass Health and Human Services committee; CR filed
upper
Mar 26, 2026
Introduced
First Reading
upper
Mar 26, 2026
Lower · Passed
Engrossed, signed, to Senate
lower
Mar 25, 2026
Committee
Referred for engrossment
lower
Mar 25, 2026
Lower · Passed
Third Reading, Measure passed: Ayes: 82 Nays: 12
lower
Mar 5, 2026
Lower · Passed
CR; Do Pass, amended by committee substitute Appropriations and Budget Committee
lower
Feb 17, 2026
Lower · Passed
Recommendation to the full committee; Do Pass, amended by committee substitute Appropriations and Budget Health Subcommittee
lower
Feb 3, 2026
Committee
Referred to Appropriations and Budget Health Subcommittee
lower
Feb 2, 2026
Introduced
First Reading
lower
2 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 3904
Scope: OK
Hi! I can help you understand HB 3904. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline